Synopsis of recent research by authors named "Camilla Nacci"
- Camilla Nacci's research primarily focuses on colorectal cancer (CRC), particularly examining the interactions between systemic immunity, tumor microenvironment, and the impact of long-term aspirin use on CRC outcomes.
- In her 2024 study published in "Cancer," Nacci found that regular aspirin use is associated with activation of immune surveillance in CRC patients, suggesting potential therapeutic benefits of aspirin in managing cancer.
- Her earlier 2022 research in "Surgery" highlights that while metachronous colorectal cancers show similar microsatellite instability frequencies to primary lesions, they exhibit lower lymphomononuclear cell infiltration, hinting at different immune response mechanisms in these cancers.
